Chimonas S, Mamoor M, Zimbalist SA, Barrow B, Bach PB, Korenstein D, et al. Mapping conflict of interests: scoping review. BMJ. 2021;375:e066576. https://doi.org/10.1136/bmj-2021-066576.
Hofman K, Shenoy GN, Chak V, Balu-Iyer SV. Pharmaceutical aspects and clinical evaluation of COVID-19 vaccines. Immunol Invest. 2021;50(7):743–79.
Taylor D. The pharmaceutical industry and the future of drug development. In: Hester RE, Harrison RM, editors. Pharmaceuticals in the environment. The Royal Society of Chemistry; 2015. p. 0. https://doi.org/10.1039/9781782622345-00001
Rusu A, Kuokkanen K, Heier A. Current trends in the pharmaceutical industry - a case study approach. Eur J Pharm Sci. 2011;44(3):437–40. https://doi.org/10.1016/j.ejps.2011.07.008.
Marques CM, Moniz S, de Sousa JP, Barbosa-Povoa AP, Reklaitis G. Decision-support challenges in the chemical-pharmaceutical industry: findings and future research directions. Comput Chem Eng. 2020;134:106672. https://doi.org/10.1016/j.compchemeng.2019.106672
Antoncic B, Hisrich RD. Clarifying the intrapreneurship concept. J Small Bus Enterp Dev. 2003;10(1):7–24. https://doi.org/10.1108/14626000310461187.
Dukart H, Lanoue L, Rezende MA, Rutten P. Emerging from disruption: the future of pharma operations strategy [Internet]. McKinsey. 2022. https://www.mckinsey.com/capabilities/operations/our-insights/emerging-from-disruption-the-future-of-pharma-operations-strategy.
Alexeenko A, Topp E. Future directions. In: Drying technologies for biotechnology and pharmaceutical applications. 2020; 355–72. https://doi.org/10.1002/9783527802104.ch15
Buchholz S. Future manufacturing approaches in the chemical and pharmaceutical industry. Chem Eng Process Process Intensif. 2010;49(10):993–5 https://www.sciencedirect.com/science/article/pii/S0255270110002035.
Zaharee A, Davami F. The pharmaceutical industry in Iran: background and technology trends that will reshape the market. 2017. https://doi.org/10.1057/978-1-137-57257-8_9.
Shih HH, Miller P, Harnish DC. An Overview of the discovery and development process for biologics. In: Pharmaceutical sciences encyclopedia. 2013. pp. 1–28. https://doi.org/10.1002/9780470571224.pse500
Buchholz S, Mleczko L. Microreactors in industrial applications for intermediates and APIs. VDI Ber. 2008;2039:177–81.
Kapoor Y, Meyer RF, Meyer BK, DiNunzio JC, Bhambhani A, Stanbro J, et al. Flexible Manufacturing: the Future State of Drug Product Development and commercialization in the Pharmaceutical Industry. J Pharm Innov. 2021;16(1):2–10.
Ke WA, Hui ZH, Yihong CA, Junfei YI, Xiaofang YU, Yaonan WA. Intelligent robots and key technologies for pharmaceutical production. Comput Integr Manuf Syst. 2022;28(7):1981.
Trenfield SJ, Awad A, Madla CM, Hatton GB, Firth J, Goyanes A, et al. Shaping the future: recent advances of 3D printing in drug delivery and healthcare. Expert Opin Drug Deliv. 2019;16(10):1081–94.
Peters MDJ, Marnie C, Tricco AC, Pollock D, Munn Z, Alexander L, McInerney P, Godfrey CM, Khalil H. Updated methodological guidance for the conduct of scoping reviews. JBI Evidence Synthesis. 2020;18(10):2119–26. https://doi.org/10.11124/JBIES-20-00167.
Arksey H, O’Malley L. Scoping studies: towards a methodological framework. Int J Soc Res Methodol. 2005;8(1):19–32. https://doi.org/10.1080/1364557032000119616.
Munn Z, Peters MD, Stern C, Tufanaru C, McArthur A, Aromataris E. Systematic review or scoping review? Guidance for authors when choosing between a systematic or scoping review approach. BMC Med Res Methodol. 2018;18(1):143. https://doi.org/10.1186/s12874-018-0611-x.
Article PubMed PubMed Central Google Scholar
Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editors. Cochrane handbook for systematic reviews of interventions. Wiley; 2019.
Peters MD, Godfrey CM, Khalil H, McInerney P, Parker D, Soares CB. Guidance for conducting systematic scoping reviews. Int J Evid Based Healthc. 2015;13(3):141–6. https://doi.org/10.1097/XEB.0000000000000050.
Shafiei N, Ford JL, Morecroft CW, Lisboa PJ, Taylor MJ, Mouzughi Y. Transformation in the pharmaceutical industry–a systematic review of the literature. PDA J Pharm Sci Technol. 2013;67(2):105–22.
Viraktamath SV, Shet CP, Nayak PR. Artificial Intelligence and its application in Speech Recognition. Bonfring Int J Res Commun Eng. 2016;6(Special Issue):48–51.
Mrak MK, Bodiroga Vukobrat N, Sokolić D. Personalized medicine industry model development. Management: Journal of Contemporary Management Issues. 2017;22(2):49–64.
Brandes R, Robotics. Trend of the future in the pharmaceutical industry. Pharm Ind. 2017;79(4):554–9.
Ding BY. Pharma Industry 4.0: literature review and research opportunities in sustainable pharmaceutical supply chains. Process Saf Environ Prot. 2018;119:115–30.
Aldieri L, Bruno B, Senatore L, Vinci CP. The future of pharmaceuticals industry within the triad: the role of knowledge spillovers in innovation process. Futures. 2020;122:102600.
Baines D, Nørgaard LS, Babar ZUD, Rossing C. The Fourth Industrial Revolution: will it change pharmacy practice? Res Social Adm Pharm. 2020;16(9):1279–81.
Uddin M. Blockchain Medledger: Hyperledger fabric enabled drug traceability system for counterfeit drugs in pharmaceutical industry. Int J Pharm. 2021;597:120235.
Arden NS, Fisher AC, Tyner K, Lawrence XY, Lee SL, Kopcha M. Industry 4.0 for pharmaceutical manufacturing: preparing for the smart factories of the future. Int J Pharm. 2021;602:120554.
Dnyaneshwar K, Gaurav S, Debleena P. Artificial intelligence in the pharmaceutical sector: current scene and future prospect. The future of pharmaceutical product development and research.
Bhattacharya S, Reang HB, Golani P, Nagdev S, Lodhi DS, Mude G. Versatile robots and their predomination in pharmaceutical industries. Int J Pharm Res. 2022;14(3).
Mukhlas A, Talip BA, Mustapha JC, Ismail S. Industry 4.0 (IR 4.0) for pharmaceutical industry: an exploratory review. In: 2022 International Visualization, Informatics and Technology Conference (IVIT). IEEE; 2022. pp. 103–109.
Narayanan RR, Durga N, Nagalakshmi S. Impact of Artificial Intelligence (AI) on Drug Discovery and Product Development. INDIAN J Pharm Educ Res. 2022;56(3):S387–97.
Suzuki H, Kurosawa S, Marcella S, Kanba M, Koretaka Y, Tsuji A et al. How AI application in pharmaceutical industries is beneficial to materials science. J Phys D-Applied Phys. 2022;55(24).
Martinelli DD. Generative machine learning for de novo drug discovery: a systematic review. Comput Biol Med. 2022;145:105403.
Osouli-Bostanabad K, Masalehdan T, Kapsa RMI, Quigley A, Lalatsa A, Bruggeman KF, et al. Traction of 3D and 4D Printing in the Healthcare Industry: from drug delivery and analysis to Regenerative Medicine. ACS Biomater Sci Eng. 2022;8(7):2764–97.
Kramlinger VM, Dalvie D, Heck CJS, Kalgutkar AS, O’Neill J, Su D, et al. Future of Biotransformation Science in the Pharmaceutical Industry. Drug Metab Dispos. 2022;50(3):258–67.
Zakari N, Al-Razgan M, Alsaadi A, Alshareef H, Al Saigh H, Alashaikh L, et al. Blockchain technology in the pharmaceutical industry: a systematic review. PeerJ Comput Sci. 2022;8:e840.
Article PubMed PubMed Central Google Scholar
Betz UAK, Arora L, Assal RA, Azevedo H, Baldwin J, Becker MS et al. Game changers in science and technology - now and beyond. Technol Forecast Soc Change [Internet]. 2023;193(May):122588. https://doi.org/10.1016/j.techfore.2023.122588
Debnath B, Shakur MS, Bari ABMM, Saha J, Porna WA, Mishu MJ, et al. Assessing the critical success factors for implementing industry 4.0 in the pharmaceutical industry: implications for supply chain sustainability in emerging economies. PLoS ONE. 2023;18(6):e0287149.
Article PubMed PubMed Central Google Scholar
Zhao A, Wu Y. Future implications of ChatGPT in pharmaceutical industry: drug discovery and development. Front Pharmacol. 2023;14:1194216.
Article PubMed PubMed Central Google Scholar
Kramer LD, Perhach JL. Perspective of the pharmaceutical industry. In: Controlled Clinical Trials in Neurological Disease. Boston: Springer US; 1990. pp. 97–104.
Amir-Aslani A, Mangematin V. The future of drug discovery and development: shifting emphasis towards personalized medicine. Technol Forecast Soc Change. 2010;77(2):203–17. https://doi.org/10.1016/j.techfore.2009.09.005.
Cottens S, Eaton M, Fuhr J, Geary S, Johnson DS, Li G, et al. Ask the experts: future of the pharmaceutical industry. Future Med Chem. 2011;3(15):1863–72.
Bradfield R, El-Sayed H. Four scenarios for the future of the pharmaceutical industry. Technol Anal Strateg Manag. 2009;21(2):195–212.
Buchholz S. Future manufacturing approaches in the chemical and pharmaceutical industry. Chem Eng Process Intensif. 2010;49(10):993–5.
Tolias P. A possible future for the pharmaceutical industry. Per Med. 2014;11(8):723–5.
Yamamoto Y, Kanayama N, Nakayama Y, Matsushima N. Current status, issues and future prospects of personalized medicine for each disease. J Pers Med. 2022;12(3):444.
Article PubMed PubMed Central Google Scholar
Jørgensen JT. Twenty years with personalized medicine: past, present, and future of individualized pharmacotherapy. Oncologist. 2019;24(7):e432–40.
Article PubMed PubMed Central Google Scholar
Williamson R, Anderson W, Duckett S, Frazer I, Hillyard C, Kowal E, et al. The future of precision medicine in Australia. Australian Council of Learned Academies (ACOLA); 2018.
Harvey A, Brand A, Holgate ST, Kristiansen LV, Lehrach H, Palotie A, et al. The future of technologies for personalised medicine. N Biotechnol. 2012;29(6):625–33.
Comments (0)